Purification of human ceruloplasmin as a by-product of C1-inhibitor

Ferdinand Kouoh Elombo, Miryana Radosevich, Michel Poulle, Jacques Descamps, Sami Chtourou, Thierry Burnouf, Jean Pierre Catteau, Jean Luc Bernier, Nicole Cotelle

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)


Human ceruloplasmin (Cp) has been purified from cryoprecipitate-poor plasma as a by-product of the C1-inhibitor production chain. Highly purified Cp was obtained by subsequent ion-exchange chromatography on sulfate-Fractogel EMD and TMAE-Fractogel EMD. Treatments for viral safety included application of the solvent-detergent method and two nanofiltration steps using 35- and 15-nm pore size filters at the end of the process. Overall antigen yield was 95 (±5)%. Purified human ceruloplasmin was studied by electron spin resonance (ESR) to characterize its different types of copper complexes and to check its antioxidant properties. We distinguished three types of complexes: One type-2 Cu(II) with g//=2.25 and A//=180 G and two type-1 Cu(II) exhibiting different narrow hyperfine splitting (A//=72 G and A//=90 G) with close g//(2.20 and 2.21). Purified Cp has a specific activity of 24.5±0.2 mU/mg of proteins. This process provides a method for Cp purification that could be easily integrated into modern plasma fractionation.
頁(從 - 到)1406-1409
期刊Biological and Pharmaceutical Bulletin
出版狀態已發佈 - 2000

ASJC Scopus subject areas

  • 分子醫學
  • 藥理學、毒理學和藥劑學 (全部)


深入研究「Purification of human ceruloplasmin as a by-product of C1-inhibitor」主題。共同形成了獨特的指紋。